NCT02140775

Brief Summary

The current study is a randomized clinical trial comparing Behavioral Activation counseling with supportive counseling for HIV+ participants presenting with clinically significant fatigue whose energy has improved with armodafinil, who have the goal of returning to work or vocational training but have not done so on their own. A second cohort of HIV+ participants without significant fatigue at baseline, but who also have the goal of returning to work, will also be randomized to either Behavioral Activation counseling or supportive counseling. In both cohorts, the primary outcome is level of success regarding an employment related goal.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
138

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2014

Completed
17 days until next milestone

First Submitted

Initial submission to the registry

April 18, 2014

Completed
28 days until next milestone

First Posted

Study publicly available on registry

May 16, 2014

Completed
4.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2019

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2019

Completed
10 months until next milestone

Results Posted

Study results publicly available

March 16, 2020

Completed
Last Updated

March 16, 2020

Status Verified

March 1, 2020

Enrollment Period

5 years

First QC Date

April 18, 2014

Results QC Date

January 28, 2020

Last Update Submit

March 13, 2020

Conditions

Keywords

HIVAIDSFatiguearmodafinilUnemployment

Outcome Measures

Primary Outcomes (1)

  • Goal Attainment Scale - Modified (GAS): Responder (Score of 3 - Goal Achieved) vs. Non-Responder (Score of 1 or 2 - Goal NOT Achieved)

    Goal Attainment Scale - Prior to the beginning of counseling, the patient met with a member of the clinical team to develop an outcome GAS scale specific to their personal return to work goal. A goal was carefully established to be obtainable within the framework of 3-6 months, and to have observable anchors that could be scored on 3 outcome levels. A score of 3 indicates that they achieved their predetermined work goal and they were considered a "Responder" to the counseling. A score 2 indicates that some of the specific steps were taken towards the goal, but that it was not fully achieved. A score of 1 indicates that few or no steps were taken. Participants who scored 1 or 2 on their GAS scale were considered to be "Non-Responders." The Primary outcome presented below includes the number of participants who achieved their work-related goal (a score on the GAS scale of 3) and are considered RESPONDERS to counseling.

    GAS Goal Responder vs. Goal Non-Responder will be assessed at Follow Up (3-6 months after the end of counseling)

Secondary Outcomes (2)

  • Environmental Reward Observation Scale (EROS)

    EROS will be measured at Follow-up (3-6 months after the end of counseling)

  • Behavioral Activation for Depression Scale (BADS)

    BADS will be measured Follow-up (3-6 months after the end of counseling)

Study Arms (2)

Behavioral Activation Counseling

EXPERIMENTAL

Behavioral Activation counseling is a manualized intervention adapted from a behavioral activation treatment for depression (BAT-D) and provides a basic foundation for behavior change. The individual sessions last one hour and are scheduled every two weeks. The counseling offers a brief, structured approach to identifying and scheduling activities in life areas to reduce avoidant behavior and increase activity level with the goal of achieving employment or enroll in training.

Behavioral: Behavioral Activation Counseling

Supportive Counseling

ACTIVE COMPARATOR

Supportive Counseling sessions will follow the same schedule and the Behavioral Activation Counseling, meeting for one hour every two weeks. The content of the sessions will be guided by the participant. The counselor will provide an accepting environment for the participant to explore his/her feelings about these topics.

Behavioral: Behavioral Activation Counseling

Interventions

Behavioral Activation counseling is a manualized intervention adapted from a behavioral activation treatment for depression (BAT-D) and provides a basic foundation for behavior change. The individual sessions last one hour and are scheduled every two weeks. The counseling offers a brief, structured approach to identifying and scheduling activities in life areas to reduce avoidant behavior and increase activity level with the goal of achieving employment or enroll in training.

Also known as: Behavioral Activation Therapy
Behavioral Activation CounselingSupportive Counseling

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • HIV+, age 18-70, and under the care of a medical provider
  • Clinically significant fatigue (Score of 4.5+ on Fatigue Severity Scale) and impairment on at least one category of role function (MOS) with duration of 3+ months (Does not apply to the cohort without fatigue)
  • Speaks English (reads English at high school level or shows comprehension in Evaluation to Consent procedure).
  • Able and willing to give informed consent
  • (Fecund Women): Uses barrier method of contraception
  • Patient seeks either work or job-related training

You may not qualify if:

  • Untreated Major Depression: (Structured Clinical Interview for Diagnostic and Statistical Manual IV (DSM-IV), (SCID) Depression Module;17-item Hamilton Rating Scale for Depression (HAM-D) \>18).
  • Untreated hypogonadism, hypothyroidism or anemia (labs out of range).
  • Unstable medical condition
  • Left ventricular hypertrophy; symptomatic mitral valve prolapse (EKG; medical history)
  • Started testosterone in past 4 weeks
  • Started antidepressant medication in past 6 weeks
  • Substance abuse/dependence
  • Current clinically significant suicidal ideation
  • History or current psychosis or bipolar disorder
  • Pregnancy or breast feeding
  • Untreated insomnia (Score\>3 on 3 HAM-D sleep items).
  • Currently taking stimulant medication of past non-responder to armodafinil

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Callen-Lorde Community Health Center

New York, New York, 10011, United States

Location

New York State Psychiatric Institute

New York, New York, 10032, United States

Location

MeSH Terms

Conditions

HIV InfectionsFatigueAcquired Immunodeficiency Syndrome

Condition Hierarchy (Ancestors)

Blood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsSlow Virus Diseases

Results Point of Contact

Title
Dr. Martin McElhiney
Organization
New York State Psychiatric Institute

Study Officials

  • Judith G Rabkin, Ph.D., MPH

    Research Scientist VI

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Clinical Psychiatry

Study Record Dates

First Submitted

April 18, 2014

First Posted

May 16, 2014

Study Start

April 1, 2014

Primary Completion

March 31, 2019

Study Completion

May 31, 2019

Last Updated

March 16, 2020

Results First Posted

March 16, 2020

Record last verified: 2020-03

Locations